Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials

Blood Pressure Control in Chronic Kidney Disease: Is Less Really More?

(2010) J. B. Lewis   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Dual RAS Therapy Not on Target, but Fully Alive

(2010) H.J. Lambers Heerspink et al.   NEPHRON CLINICAL PRACTICE

Home and ambulatory blood pressure monitoring in chronic kidney disease

(2009) Rajiv Agarwal   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study

(2009) Peter Sleight et al.   JOURNAL OF HYPERTENSION

Supramaximal Dose of Candesartan in Proteinuric Renal Disease

(2009) E. Burgess et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in Diabetes

(2009) T. Ninomiya et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events

(2008)   NEW ENGLAND JOURNAL OF MEDICINE